VENETIS, KONSTANTINOS
VENETIS, KONSTANTINOS
Dipartimento di Oncologia ed Emato-Oncologia
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
2025 K. Venetis, C. Frascarelli, L.B. Bielo, G. Cursano, R. Adorisio, M. Ivanova, E. Mane, V. Peruzzo, A. Concardi, M. Negrelli, M. D'Ercole, F.M. Porta, Y. Zhan, A. Marra, D. Trapani, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco
Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
2025 R. Adorisio, D. Ciardiello, A. Rappa, L. Gervaso, G. Pelizzari, L. Marinucci, N. Fusco, M.G. Zampino, N. Fazio, K. Venetis, E. Guerini-Rocco
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
2024 F. Pepe, K. Venetis, G. Cursano, C. Frascarelli, P. Pisapia, D. Vacirca, C. Scimone, A. Rappa, G. Russo, E. Mane, F. Pagni, I. Castellano, G. Troncone, C.D. Angelis, G. Curigliano, E. Guerini-Rocco, U. Malapelle, N. Fusco
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
2024 E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
2024 M. Ivanova, C. Frascarelli, B. Cerbelli, M.G. Pignataro, A. Pernazza, K. Venetis, E. Sajjadi, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, P. Graziano, M. Martini, G. D'Amati, N. Fusco
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations
2024 L. Boscolo Bielo, E. Guerini Rocco, D. Trapani, P. Zagami, B. Taurelli Salimbeni, A. Esposito, C. Belli, E. Crimini, K. Venetis, E. Munzone, N. Fusco, C. Criscitiello, A. Marra, G. Curigliano
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
BREAST CANCER DURING PREGNANCY AS A SPECIAL TYPE OF EARLY-ONSET BREAST CANCER: INSIGHTS INTO THE TUMOR MICROENVIRONMENT AND IMMUNE TRANSCRIPTOME
2023 K. Venetis
Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies
2023 G. Grizzi, K. Venetis, N. Denaro, M. Bonomi, A. Celotti, A. Pagkali, J. Claus Hahne, G. Tomasello, F. Petrelli, N. Fusco, M. Ghidini
Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients”
2023 E. Sajjadi, K. Venetis, N. Fusco
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study
2023 E.M.C. Rossi, A. Invento, F. Pesapane, E. Pagan, V. Bagnardi, N. Fusco, K. Venetis, V. Dominelli, C. Trentin, E. Cassano, L. Gilardi, M. Mazza, M. Lazzeroni, F. De Lorenzi, P. Caldarella, A. De Scalzi, A. Girardi, C. Sangalli, L. Alberti, V. Sacchini, V. Galimberti, P. Veronesi
Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances
2023 M. Ivanova, L. Bottiglieri, E. Sajjadi, K. Venetis, N. Fusco
In-house homologous recombination deficiency testing in ovarian cancer: A multi-institutional Italian pilot study
2023 F. Pepe, E. Guerini-Rocco, M. Fassan, N. Fusco, D. Vacirca, A. Ranghiero, K. Venetis, A. Rappa, S.V. Taormina, G. Russo, E. Rebellato, G. Munari, A. Moreno-Manuel, C. De Angelis, C. Zamagni, G. Valabrega, U. Malapelle, G. Troncone, M. Barberis, A. Iaccarino
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
2023 E. Sajjadi, E. Guerini-Rocco, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, M. Ivanova, N. Fusco
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing
2023 A. Ranghiero, C. Frascarelli, G. Cursano, C. Pescia, M. Ivanova, D. Vacirca, A. Rappa, S.V. Taormina, M. Barberis, N. Fusco, E.G. Rocco, K. Venetis
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
2023 K. Venetis, F. Pepe, C. Pescia, G. Cursano, C. Criscitiello, C. Frascarelli, E. Mane, G. Russo, B. Taurelli Salimbeni, G. Troncone, E. Guerini Rocco, G. Curigliano, N. Fusco, U. Malapelle
The molecular landscape of breast mucoepidermoid carcinoma
2023 K. Venetis, E. Sajjadi, M. Ivanova, S. Andaloro, S. Pessina, C. Zanetti, A. Ranghiero, G. Citelli, C. Rossi, M. Lucioni, U. Malapelle, F. Pagni, M. Barberis, E. Guerini-Rocco, G. Viale, N. Fusco